Electroencephalography (EEG) is a fascinating noninvasive technique that measures and records the brain's electrical activity ...

By any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...

The U.S. private credit market has reached $2.1 trillion in assets under management (AUM) this year, surpassing the ...

Batman and Robin #27 hits stores this Wednesday! A mysterious new villain targets Gotham's rogues gallery. Who's hunting the ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious "techbio" company positions itself for its next phase of AI drug discovery.

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a ...

Learn how advanced AI can predict hidden building conditions, reducing costs and promoting sustainable architecture practices ...